Quantcast
Channel: WN.com - Articles related to MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
Viewing all articles
Browse latest Browse all 300

MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting

$
0
0
My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about MELA Download image MELA Sciences. (PRNewsFoto/MELA Sciences, Inc.) IRVINGTON, N.Y., Oct. 2, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that developed and is commercializing MelaFind®, the first and only FDA-approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, will participate in the American Society of Dermatologic Surgery (ASDS) Annual Meeting from October 3-6, 2013, at the Hyatt Regency in Chicago, Illinois. (Logo: ...

Viewing all articles
Browse latest Browse all 300

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>